Cargando…
Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
The therapeutic potential of melatonin as a chronobiotic cytoprotective agent to counteract the consequences of COVID-19 infections has been advocated. Because of its wide-ranging effects as an antioxidant, anti-inflammatory, and immunomodulatory compound, melatonin could be unique in impairing the...
Autores principales: | Cardinali, Daniel P., Brown, Gregory M., Pandi-Perumal, Seithikurippu R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709121/ https://www.ncbi.nlm.nih.gov/pubmed/33256258 http://dx.doi.org/10.3390/diseases8040044 |
Ejemplares similares
-
Possible Application of Melatonin in Long COVID
por: Cardinali, Daniel P., et al.
Publicado: (2022) -
Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
por: Cardinali, Daniel P, et al.
Publicado: (2022) -
Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration
por: Cardinali, Daniel P., et al.
Publicado: (2020) -
Autism Spectrum Disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin
por: Brown, Gregory M., et al.
Publicado: (2021) -
Melatonin as an Add-On Treatment of COVID-19 Infection: Current Status
por: Brown, Gregory M., et al.
Publicado: (2021)